Atlas Trials

Mesenchymal Stem Cells as First Treatment Line for Resistant Acute Graft Versus Host Disease

Clinical trial NCT02770430 · UNKNOWN

Trial details

NCT number
NCT02770430
Sponsor
Hospital de Clinicas de Porto Alegre
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Graft vs Host Disease
Start date
2015-09-01
Primary completion
2017-09-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.